RJ Reynolds
Environmental Tobacco Smoke: A Compendium of Technical Information. Chapter Eleven. Passive Smoking and Heart Disease: Epidemiology, Physiology, and Biochemistry. Comments of the Tobacco Institute. Volume I. B.
Fields
- Type
- REPORT
- Attachment
- 5994 -6146
- Site
- Executive
- Johnston Jw
- President & Ceo
- Johnston Jw
- Referenced Document
- Passive Smoking & Heart Disease: Epidemiology, Physiology, & Biochemistry, by Glantz Sa & Parmley Ww. Framingham Heart Study, by Seltzer, 890000. Mrfit. Surgeon General's 1986 (860000) Report. List of Reference Studies.
- Recipient
- Epa
- Date Loaded
- 27 Feb 1998
- Request
- 1rfp43
- Burton
- 2rfp4
- 1rfp4
- 1rfp37
- 1rfp41
- 1rfp42
- Minnesota
- 1rfp44
- Burton
- Author
- Wexler, L.M.
- Ti
- Box
- Rjr1464
- Named Person
- Sandler, D.P.
- New York Medical College
- Yale Univ
- American Home Products
- Pharmacia Opthalmics
- Blue Cross & Blue Shield
- Epidemiology Consulting Group
- Glantz, S.A.
- Parmley, W.W.
- American Public Health Assn
- Humble
- He
- Surgeon General
- Phs
- Natl Academy, O.F. Sciences
- Cornfield, J.
- Natl Research Council
- Mcgill Univ
- Epa
- Garland, C.
- Helsing, K.J.
- Hirayama, T.
- Hole, D.J.
- Gillis, C.R.
- Lee, P.N.
- Scheivelbein, H.
- Richter, F.
- Seltzer, C.
- Svendsen, K.H.
- Wynder, E.L.
- Martin
- New York Medical College
- UCSF Legacy ID
- plq14d00
Document Images
Potential biases also exist in the Sole and Gillis study.
For example, those exposed to ETS within the home may have had
higher exposures to ETS outside of the. Kome compared with
controls. A second potential bias is misclassification of women
as non-smokers when they may in fact be former smokers or current
smokers.
Although the Hole and Gillis study suggests an association
between ETS and cardiovascular mortality in non-smokers, the data
lack any statistical significance. Also, the study reports so(he
confusing and similar relative risks for active and passive
smokers, and is vulnerable to several important methodological
biases. This study would have to be replicated in a much larger
study population to achieve adequate statistical power.
D. Svendsen
With respect to the Svendsen report, one problem is possible
misclassification of the husband's smoking status either at entry
or subsequently. A second problem is that the wife's smoking
status was based on interviews with the husband, and not on
direct questioning of the wife.
There is also an alcohol-related bias in this study, as
MRFIT ETS-exposed husbands had on average two drinks more per
week more than non-ETS exposed husbands, and this alcohol effect

could explain the observed statistical significance in dose
Finally, by combining ex-smoking husbands with never
smokers, the Svendsen paper confounds any.possible past effects
of active smoking by the husband with exposure to ETS.
The XRFIT study serves in general as an exemplary
prospective trial for its design and conduct. 8owever, lack of
statistical significance, failure to control for several
confounding variables such as alcohol consumption,
misclassification, and misgrouping make it difficult to draw any
conclusions relating to ETS'exposure from the study.
The last prospective study is the work of 8elsing, Sandler
and co-workers. The first problem I see here is that the only
smoking data that were collected on every person were from 1963.
Hence, no changes in smoking habits over the 12-year period were
ascertained. In addition, no data were collected on acknowledged
risk factors for heart disease such as diet, exercise, blood
pressure, and cholesterol. Also, no ETS exposure outside the
home was measured. And finally, death certificates were obtained
only for those 1963 participants who still resided in Washington
County, Maryland, at the time of their deaths.
.__.__....~..,.,.,~:..~..~~,Y..,.........~.w,

The only retrospective case-control study in English thus
far is the work by Lee. Although this study is one of the few to
attempt to examine non-spousal ETS exposure, it raises the
methodological difficulties that plague retrospective case
control studies in general. In its finding of non-statistical
significance for any trends of association between ETS and
cardiovascular illness, the Lee paper confirms the need for
execution of better controlled prospective trials.
In 1989, He reported a retrospective study of 34 women. The
odds ratio reported was 3.0 and a significant dose response was
reported in the English language abstract of this study, which
was itself published in Chinese. Methodological problems of the
study include a small sample size and retrospective recall of
number of cigarettes smoked. It is impossible to comment further
on the study without an adequate translation of the paper from
Chinese into English, which is not feasible given the short time
period permitted for comments on this chapter.
As noted in my critique of the seven epidemiological
studies, misclassification is a pivotal variable in accurately
- 12 -

determining exposure to ETS. It is critical that a mechanism for
accurate measurement of ETS exposure, including exposure outside
the home, and adequate follow-up of exposure status be
determined. Glantz and Parmley unjustifiably minimize the
potential effects of misclassification and assert, without proof,
that the effect of misclassification errors leads to an
underestimation of the effects of ETS. Without an accurate
measure of ETS exposure, their assertion cannot be justified.
The Surgeon General's 1986 Report examines the studies of
Hirayama, Hole and Gillis, and Garland, and concludes that
"further studies on the relationship between involuntary smoking
and cardiovascular disease are needed in order to determine
whether involuntary smoking increases the risk of cardiovascular
disease."
Likewise, in 1986 the National Research Council reviewed the
prospective studies of Garland, Bole and Gillis, Hirayama, and
Svendsen, as well as several experimental designs examining the
biological plausibility of the association of ETS and
cardiovascular disease, and concluded that:
"With respect to chronic cardiovascular morbidity and
mortality, although biologically plausible, there is no
evidence of statistically significant effects due to ETS
exposure, apart from the study by Hirayama in Japan."

In my opinion, contrary to the position taken by Glantz and
Parmley, none of the more recent studies in this area provides a
basis for altering the Surgeon General's and NAS's conclusions
concerning ETS and.cardiovascular disease.
Although Glantz and Parmley contend that cultural factors do
not confound the interpretation of the ETS and CHD data, I would
argue that they do, as illustrated in the previous critiques.
Likewise, Glantz and Parmley assert that several studies showed a
dose-response relationship between increasing amounts of ETS
exposure and the risk of heart disease, and that this indicates a
"real effect" of ETS on heart disease. I believe this conclusion
is unjustified and is contradicted by a careful evaluation of the
epidemiological studies. The few studies that reported
statistically significant dose response relationships were
invalidated by serious methodological flaws.
I agree with the statement of Glantz and Parmley that most
of the studies cited do not yield statistically significant
relative risks. In addition, most of the studies have low to
moderate power and are not capable of supporting a conclusion
that ETS elevates the risk of heart disease.
The authors assert that the two studies (Helsing 1988; Hole
1989) that have power above the desirable level of 80%
"identified significant increases of heart disease with ETS
exposure," and imply that these studies should be given greater
- 14 -

weight than the other studies. This analysis fails to account
for the fact that there were only 84 cases in the Hole study, and
Helsing failed to control for important confounding variables
such as diet, exerciser blood pressure, and cholesterol.
Glantz and Parmley "pool the results of these studies to
increase the power of the tests and so produce estimates of risk
that are significantly elevated." They cite a pooled relative
risk of 1.3 for men, and in a second analysis they cite a pooled
relative risk of 1.2 for women. Even assuming that this pooling
technique is justified, both pooled relative risks fall
significantly below 2.0, which is generally regarded as necessary
to support causality in epidemiology. In addition, for many of
the reasons already cited in the individual critiques, pooling
studies that are fraught with existing biases and confounders
only leads to a pooled relative risk which combines and
strengthens the effects of the biases and confounders. Such a
meta-analysis is intrinsically unreliable.
I disagree with Glantz and Parmley's implication that
scientists currently understand the true exposure of ETS in the
home, and in the workplace. Without a mechanism for accurate
measurement of ETS exposure, including exposure outside the home,
and adequate follow-up of exposure status, it is impossible to
come to any definite conclusion as to actual ETS exposure levels.
This conclusion is supported by the findings of Schieveblein and
Richter (1984). They report that, under real-life conditions,

persons exposed to ETS inhale only one to two percent of the
amount of particulate matter takenup by active smokers. Also,
level, and the increase in carboxyhemoglobin rarely~exceeds 1%.
within a=ange that is barely distinguishable:..fr,om the,background
nicotine concentration in serum of ETS-exposed individuals is
The authors thus conclude that "passive smoking is not likely to
have an effect on the development and progression of CBD."'
At a November, 1989 international symposium on ETS'at McGill
University in Montreal, in which I participated, the participants
expressed the view that the available epidemiological studies
examining the relationship between ETS and coronary heart disease
report at most a small statistical association, and that ETS is
unlikely to contribute significantly to the incidence of coronary
heart disease. This view is in sharp disagreement with Glantz
and Parmley's conclusions, and provides further evidence of the
weaknesses of Chapter 11 of the draft EPA ETS compendium.
.~......,,,.~.~.~:a,w...~..r,..~.~_.....,.,.~..~..:~:.:,..:........~......~..~..,,,.~:~,..~.....~,..

References
Ecobichon, D.J.; Wu, J.M. En'vironmental Tobacco Smoke:
Proceedings of the International Symposium at McGill University.
Lexington Books 1990.
Environmental Tobacco Smoke - Measuring Exposures and
Assessing Health Effects, National Research Council, National
Academy Press, Washington, D.C., 1986.
Garland, C. et al. (1985). Effects of passive smoking on
ischemic Heart disease mortality of non-smokers. American
Journal of Epidemiology 121(5).
Helsing, K.J., D.P. Sandler, G.W. Constock, and E. Chee,
(1988). Heart disease mortality in non-smokers living with
smokers. American Journal of Epidemiology 127(5).
Hirayama, T. (1984). Lung cancer in Japan: Effects of
nutrition and passive smoking. Lung Cancer: Causes and
Prevention. Verlag Chemie International, Inc.
Hirayama, T. (1981). Non-Smoking wives of heavy smokers
have a higher risk of lung cancer: a study from Japan. British
Medical Journal 282:183-185.
Hole, D.J., C.R. Gillis et al. (1989). Passive smoking and
cardiorespiratory health in a general population in the west of
Scotland. British Medical Journal 299:423-427.
- 17 -

Lee, P.N., J. Chamberlain, and M.R. Alderson (1986).
Relationship of passive smoking to risk of lung cancer and other.r
smoking-associated diseases. British Journal of Cancer 54:97-105.
Schievelbein, H. and F. Richter (1984). The influence of
passive smoking on the cardiovascular system. Prevention
Medicine 13:626-644.
Seltzer, C. (1989). Framingham study data and established
wisdom about cigarette smoking and coronary disease. Journal of
Clinical Epidemiology 42(8):743-750.
Surgeon General's Report (1986). The Health Consequences of
Involuntary Smoking. U.S. Department of Health and Human
Services.
Svendsen, K.H., Lewis H. Kuller et al. (1987). Effects of
passive smoking in the multiple risk factor intervention trial.
American Journal of Epidemiology 126(5).
Wynder, E.L. (1987). Workshop on guidelines to the
epidemiology of weak associations. Prevention Medicine 16:139-
141.
